Cristina R. Ferrone

2002–2025 年に発表

206
論文数
35,271
被引用数
92
h 指数
191
i10 指数

被引用数

Cristina R. Ferrone の年別被引用数1986 年: 被引用 1 件1989 年: 被引用 1 件1999 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 5 件2004 年: 被引用 8 件2005 年: 被引用 9 件2006 年: 被引用 16 件2007 年: 被引用 21 件2008 年: 被引用 26 件2009 年: 被引用 33 件2010 年: 被引用 58 件2011 年: 被引用 94 件2012 年: 被引用 115 件2013 年: 被引用 160 件2014 年: 被引用 272 件2015 年: 被引用 359 件2016 年: 被引用 380 件2017 年: 被引用 419 件2018 年: 被引用 469 件2019 年: 被引用 1,455 件2020 年: 被引用 1,831 件2021 年: 被引用 1,864 件2022 年: 被引用 1,484 件2023 年: 被引用 1,196 件2024 年: 被引用 1,804 件2025 年: 被引用 883 件2026 年: 被引用 34 件1987〜1988 年は被引用が無いため表示していません1990〜1998 年は被引用が無いため表示していません2000〜2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,597 件、この内訳の 26%中国: 引用元論文 2,786 件、この内訳の 15.7%イタリア: 引用元論文 1,131 件、この内訳の 6.4%ドイツ: 引用元論文 965 件、この内訳の 5.5%イギリス: 引用元論文 779 件、この内訳の 4.4%日本: 引用元論文 746 件、この内訳の 4.2%フランス: 引用元論文 638 件、この内訳の 3.6%オランダ: 引用元論文 534 件、この内訳の 3%カナダ: 引用元論文 487 件、この内訳の 2.8%韓国: 引用元論文 426 件、この内訳の 2.4%オーストラリア: 引用元論文 425 件、この内訳の 2.4%スペイン: 引用元論文 379 件、この内訳の 2.1%
0%26%その他 21.5%

分野

  • Medicine62.2%
  • Biochemistry, Genetics and Molecular Biology29.7%
  • Immunology and Microbiology3.5%
  • Engineering1.7%
  • Materials Science0.9%
  • Computer Science0.3%
  • その他1.7%

トピック

  • Pancreatic and Hepatic Oncology Research10.9%
  • Cholangiocarcinoma and Gallbladder Cancer Studies4.9%
  • Cancer Immunotherapy and Biomarkers3.6%
  • Cancer, Hypoxia, and Metabolism3.1%
  • Pancreatitis Pathology and Treatment3.1%
  • Cancer Cells and Metastasis3%
  • その他71.4%

共著者

全論文

検索で開く
  1. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Bu, Monia Michaud, Sunia A. Trauger, Iris Barshack, Talia Golan, Judith Sandbank, Keith T. Flaherty, Anna Mandinova, Wendy S. Garrett, Sarah P. Thayer, Cristina R. Ferrone, Curtis Huttenhower, Sangeeta N. Bhatia, Dirk Gevers, Jennifer A. Wargo, Todd R. Golub, Ravid Straussman - Science 2017 被引用: 1,812

  2. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeanne Shen, Charles M. Vollmer, Robert A. Wolff, Brian M. Wolpin, Beth Lynn, Giby V. George - Journal of the National Comprehensive Cancer Network 2021 被引用: 1,286

  3. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway

    著者: , , , , , , , , , , , , , , , , , - Nature 2013 被引用: 2,007

  4. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lan Nguyễn, Toni Delorey, Devan Phillips, Jaimie L. Barth, Marina Kem, Clifton Rodrigues, Debora Ciprani, Jorge Roldán, Piotr Zelga, Vjola Jorgji, Jonathan Chen, Zackery A. Ely, Daniel Zhao, Kit Fuhrman, Robin Fropf, Joseph Beechem, Jay S. Loeffler, David P. Ryan, Colin D. Weekes, Cristina R. Ferrone, Motaz Qadan, Martin J. Aryee, Rakesh K. Jain, Donna Neuberg, Jennifer Y. Wo, Theodore S. Hong, Ramnik J. Xavier, Andrew J. Aguirre, Orit Rozenblatt–Rosen, Mari Mino–Kenudson, Carlos Fernández‐del Castillo, Andrew S. Liss, David T. Ting, Tyler Jacks, Aviv Regev - Nature Genetics 2022 被引用: 413

  5. Neoadjuvant therapy for pancreatic cancer

    著者: , , , , , , , - Nature Reviews Clinical Oncology 2023 被引用: 358

  6. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2016 被引用: 864

  7. B7-H3: An Attractive Target for Antibody-based Immunotherapy

    著者: , , , , , , - Clinical Cancer Research 2020 被引用: 384

  8. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors

    著者: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 917

  9. Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer Y. Wo, Theodore S. Hong, Liliana Bordeianou, Cristina R. Ferrone, Motaz Qadan, Hiroko Kunitake, David L. Berger, Rocco Ricciardi, James C. Cusack, Victoria M. Raymond, AmirAli Talasaz, Genevieve M. Boland, Ryan B. Corcoran - Clinical Cancer Research 2021 被引用: 361

  10. Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism

    著者: , , , , , , , , , , , , , , , , - Nature 2015 被引用: 807

  11. Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theodore S. Hong - JAMA Oncology 2019 被引用: 510

  12. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesca Bersani, Adam Langenbucher, Vishal Thapar, Robert Morris, Ulrich F. Wellner, Oliver Schilling, Michael S. Lawrence, Andrew S. Liss, Miguel N. Rivera, Vikram Deshpande, Cyril H. Benes, Shyamala Maheswaran, Daniel A. Haber, Carlos Fernández‐del‐Castillo, Cristina R. Ferrone, Wilhelm Haas, Martin J. Aryee, David T. Ting - Cell 2019 被引用: 543

  13. TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robin Kate Kelley, Alberto Bardelli, A. John Iafrate, William C. Hahn, Cyril H. Benes, David T. Ting, Hiroshi Hirai, Gad Getz, Dejan Juric, Andrew X. Zhu, Ryan B. Corcoran, Nabeel Bardeesy - Cancer Discovery 2019 被引用: 371

  14. Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2016 被引用: 465

  15. Mutant IDH Inhibits IFNγ–TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hongwu Zheng, Robert T. Manguso, Nabeel Bardeesy - Cancer Discovery 2021 被引用: 147

  16. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients

    著者: , , , , , , , , , , , , , - Nature Cancer 2024 被引用: 83

  17. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah P. Thayer, Colin D. Weekes, Robert A. Wolff, Brian M. Wolpin, Jennifer L. Burns, Susan Darlow - Journal of the National Comprehensive Cancer Network 2017 被引用: 1,030

  18. BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma

    著者: , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2013 被引用: 938

  19. Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 746

  20. Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2014 被引用: 544

  21. Benchmarks in Pancreatic Surgery

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John B. Martinie, Horacio J. Asbun, Mustapha Adham, Richard D. Schulick, Hauke Lang, Bas Groot Koerkamp, Marc G. Besselink, Ho‐Seong Han, Masaru Miyazaki, Cristina R. Ferrone, Carlos Fernández-del Castillo, Keith D. Lillemoe, Laurent Sulpice, Karim Boudjéma, Marco Del Chiaro, Joan Fabregat, David A. Kooby, Peter J. Allen, Harish Lavu, Charles J. Yeo, Eduardo Barroso, Keith Roberts, Paolo Muiesan, Alain Sauvanet, Akio Saiura, Christopher L. Wolfgang, John L. Cameron, Ugo Boggi, Dong Sup Yoon, Claudio Bassi, Milo A. Puhan, Pierre‐Alain Clavien - Annals of Surgery 2019 被引用: 317

  22. Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Annals of Surgery 2014 被引用: 837

  23. EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive Cholangiocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2022 被引用: 97

  24. Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma

    著者: , , , , , , , , , , , , , , , , , - JAMA Oncology 2018 被引用: 543